Chi-Med starts phase Ib/II trial of sulfatinib in NET and BTC patients

Image: Chi-Med launches phase Ib/II trial of sulfatinib in NET and BTC patients. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.